Type 2 diabetes: The creamy dessert proven to lower blood sugar and prevent the condition

TYPE 2 diabetes causes a person ’s blood sugar levels to become too high and can lead to serious long-term health problems if left untreated. Limiting certain foods is one way to control blood sugar. Another could be to eat more of a certain creamy dessert.
Source: Daily Express - Health - Category: Consumer Health News Source Type: news

Related Links:

IJERPH, Vol. 16, Pages 1435: Adulthood Socioeconomic Position and Type 2 Diabetes Mellitus—A Comparison of Education, Occupation, Income, and Material Deprivation: The Maastricht Study International Journal of Environmental Research and Public Health doi: 10.3390/ijerph16081435 Authors: Yuwei Qi Annemarie Koster Martin van Boxtel Sebastian Köhler Miranda Schram Nicolaas Schaper Coen Stehouwer Hans Bosma In an effort to better quantify the impact of adulthood socioeconomic circumstances on prediabetes and type 2 diabetes (T2DM), we set out to examine the relative importance of four adulthood...
Source: International Journal of Environmental Research and Public Health - Category: Environmental Health Authors: Tags: Article Source Type: research
(CNN) — Whether you eat breakfast might be linked with your risk of dying early from cardiovascular disease, according to a new study. Skipping breakfast was significantly associated with an increased risk of cardiovascular-related death, especially stroke-related death, in the study published in the Journal of the American College of Cardiology on Monday. After a person’s age, sex, race, socioeconomic status, diet, lifestyle, body mass index and disease status were taken into account, the study found that those who never had breakfast had a 87% higher risk of cardiovascular mortality compared with people who h...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - Category: Consumer Health News Authors: Tags: Health News CNN Heart Disease Source Type: news
The Monarch external Trigeminal Nerve Stimulation (eTNS) System made history last week after it became the first device to win a nod from FDA to treat attention deficit hyperactivity disorder (ADHD). It should be noted the technology has had CE mark since 2015. Monarch was developed by NeuroSigma and is indicated to help treat 7 to 12-year-olds suffering from ADHD. What makes this de novo clearance from FDA so significant is that typically pharmaceutical solutions are used to treat patients suffering from the neurological disorder. Monarch is about the size of a cellphone. The device generates a low-level electrical pulse ...
Source: MDDI - Category: Medical Devices Authors: Tags: Digital Health Source Type: news
In patients with type 2 diabetes and hyperlipidemia or mixed dyslipidemia on a maximally tolerated statin, treatment with evolocumab lowers low-density-lipoprotein cholesterol (LDL-C) and improves levels of other lipids, researchers say.Reuters Health Information
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Diabetes & Endocrinology News Source Type: news
MONDAY, April 22, 2019 -- New research suggests a first-line drug for treating type 2 diabetes -- metformin -- may help people with pre-diabetes maintain long-term weight loss. People who lost weight while taking metformin maintained a loss of...
Source: Drugs.com - Daily MedNews - Category: General Medicine Source Type: news
Condition:   Diabetes Mellitus, Type 2 Interventions:   Drug: Insulin 287;   Drug: Insulin glargine U100 Sponsor:   Novo Nordisk A/S Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
TYPE 2 diabetes is a condition that causes a person ’s blood sugar level to become too high. Left untreated, it can lead to serious long-term health problems. When it comes to preventing the condition or keeping blood sugar in check, some experts recommend eating a certain Latin American food.
Source: Daily Express - Health - Category: Consumer Health News Source Type: news
Authors: Simons LA Abstract Statin drugs reduce low-density lipoprotein (LDL)-cholesterol (LDL-C) and cardiovascular risk. Ezetimibe may be used to supplement statin therapy, or used alone in cases of statin intolerance. Statin-associated side effects do occur, especially muscle symptoms and new onset diabetes, but they do not detract from the benefits of statin therapy. Inhibitors of proprotein convertase subtilisin/kexin type 9 (PCSK9) reduce LDL-C and cardiovascular risk. Evolocumab is subsidised in Australia for patients with familial hypercholesterolaemia when LDL-C is not adequately controlled with maximum do...
Source: Medical Journal of Australia - Category: General Medicine Tags: Med J Aust Source Type: research
Conclusions/interpretationThis study indicates that scWAT may be an important mediator of exercise-induced improvements in insulin sensitivity, especially in overweight dysglycaemic individuals at increased risk of developing type 2 diabetes.
Source: Diabetologia - Category: Endocrinology Source Type: research
I appreciate the interest of Babayigit et al. in our recent study entitled “Comparisons of changes in the adapted diabetes complications severity index and CHA2DS2-VASc score for atrial fibrillation risk stratification in patients with type 2 diabetes mellitus: a nationwide cohort study” [1]. This is an investigation about the comparative effect of dynamic changes in t wo different risk scores for the development of atrial fibrillation (AF) - the CHA2DS2-VASc score and the adapted diabetes complications severity index (DCSI) score - in patients with new onset diabetes mellitus (DM).
Source: International Journal of Cardiology - Category: Cardiology Authors: Tags: Letter to the Editor Source Type: research
More News: Diabetes | Diabetes Type 2 | Endocrinology | Health | Sugar